Patha (Cissampelos pareira)

Patha (Cissampelos pareira) is an Ayurvedic herb whose primary bioactive alkaloids — hayatine, cissampeline, and pelosine — exert anti-inflammatory, antipyretic, and antimicrobial effects by modulating cyclooxygenase pathways and disrupting microbial cell membranes. It has been used in traditional medicine for fever, urinary disorders, and infections for centuries, with modern preclinical studies beginning to validate these mechanisms.

Category: Ayurveda Evidence: 2/10 Tier: Preliminary (in-vitro/animal)
Patha (Cissampelos pareira) — Hermetica Encyclopedia

Origin & History

Patha is the Ayurvedic name for the roots of Cissampelos pareira L., a climbing shrub native to tropical regions including India, distinguishing it from substitutes like Cyclea peltata and Stephania japonica. The roots are typically extracted using 50% aqueous ethanol or methanol to obtain alkaloid-rich preparations containing isoquinoline alkaloids, terpenoids, tannins, and other bioactive compounds.

Historical & Cultural Context

In Ayurveda, Patha roots (C. pareira var. hirsuta) have been used for centuries to treat stomach pain, fever, skin diseases, cardiac pain, urinary problems, and skin infections. It is recognized as a key herb in the Indian traditional medicine system, with roots fulfilling Ayurvedic pharmacopoeial claims for quality and efficacy.

Health Benefits

• Antipyretic (fever-reducing) effects demonstrated in animal models, with methanol root extracts showing significant activity compared to substitutes (preliminary evidence)
• Antimicrobial activity observed in preclinical studies, supporting traditional use for infections (preliminary evidence)
• Traditional use for stomach pain and digestive issues, though lacking clinical validation (traditional evidence only)
• Reported anti-inflammatory and antidiabetic activities in preclinical reviews, requiring clinical trials for confirmation (preliminary evidence)
• Historical application for urinary problems and skin conditions in Ayurvedic medicine (traditional evidence only)

How It Works

The bisbenzylisoquinoline alkaloids in Cissampelos pareira, particularly hayatine and cissampeline, inhibit cyclooxygenase-2 (COX-2) enzyme activity, reducing prostaglandin E2 synthesis and thereby producing antipyretic and anti-inflammatory effects. Pelosine, a morphine-type alkaloid, may interact with opioid and muscarinic receptors, contributing to smooth muscle relaxation and antispasmodic properties relevant to urinary tract applications. Antimicrobial activity is attributed to disruption of bacterial cell membrane integrity and inhibition of microbial enzyme systems, as demonstrated in methanol and ethanol root extracts against gram-positive and gram-negative organisms.

Scientific Research

No human clinical trials, RCTs, or meta-analyses have been conducted on Patha according to available research. All evidence is limited to preclinical animal and in vitro studies, with a comprehensive review explicitly calling for clinical trials to validate the reported pharmacological activities.

Clinical Summary

The majority of evidence supporting Patha's therapeutic effects comes from in vitro and rodent-based preclinical studies rather than human clinical trials. Methanol root extracts administered to febrile rat models demonstrated statistically significant temperature reduction compared to control groups, with activity approaching that of standard antipyretic references in some assays. Antimicrobial disc diffusion studies have shown inhibitory zones against pathogens including Staphylococcus aureus and Escherichia coli, though minimum inhibitory concentrations vary widely between studies. No large-scale randomized controlled human trials have been published to date, placing the overall evidence level as preliminary; conclusions cannot yet be extrapolated to standardized clinical use.

Nutritional Profile

{"macronutrients": {"protein": "Not well-documented", "fiber": "Not well-documented"}, "micronutrients": {"vitamins": {"Vitamin C": "Trace amounts, specific concentration not well-documented"}, "minerals": {"Calcium": "Trace amounts, specific concentration not well-documented", "Iron": "Trace amounts, specific concentration not well-documented"}}, "bioactive_compounds": {"Alkaloids": "Cissampeline, concentration not well-documented", "Flavonoids": "Trace amounts, specific concentration not well-documented", "Tannins": "Trace amounts, specific concentration not well-documented"}, "bioavailability_notes": "Limited data on bioavailability; traditional use suggests some efficacy, but clinical validation is lacking."}

Preparation & Dosage

No clinically studied dosage ranges are available due to absence of human trials. Preclinical toxicity studies used 1-2 g/kg/day orally of 50% aqueous ethanolic root extract for 28 days in rats without adverse effects. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Turmeric, Ginger, Ashwagandha, Triphala, Boswellia

Safety & Interactions

Cissampelos pareira contains curare-like alkaloids, including hayatine, which exhibit neuromuscular blocking properties at higher doses, posing a theoretical risk of muscle relaxation or respiratory depression if consumed in large quantities. Pregnancy is considered a contraindication in traditional Ayurvedic texts, and animal data suggest potential uterotonic activity, making use during pregnancy or breastfeeding inadvisable without medical supervision. Co-administration with anticoagulants, antihypertensives, or neuromuscular blocking agents used in anesthesia warrants caution due to possible additive or potentiating pharmacological interactions. Formal human safety trials are lacking, so individuals with liver or kidney conditions should consult a qualified practitioner before use.